Organoid Technology for Tissue Engineering

    Juan He, Xiaoyu Zhang, Xinyi Xia, Ming Han, Fei Li, Chunfeng Li, Yunguang Li, Dong Gao
    TLDR Organoid technology helps create mini-organs for studying diseases and testing drugs.
    Organoid technology emerged as a significant advancement in tissue engineering, allowing for the creation of 3D structures from stem cells that mimic in vivo organs. By 2020, this technology had progressed to include brain and skin organoids, which provided insights into tissue development and disease modeling. Despite challenges such as the lack of vasculature in brain organoids, researchers developed vascularized brain organoids and skin organoids capable of hair follicle formation. Organoids for various endoderm-derived organs, including the thyroid, lung, stomach, liver, pancreas, intestine, and colon, were successfully created, offering models that mimic their in vivo counterparts. However, limitations in maturity, size, and complexity remained, as current organoids could not fully replicate in vivo organs. Advances in 3D bioprinting and stem cell biology were expected to address these challenges, enhancing the utility of organoids in tissue engineering and clinical research.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results